NCT00236028View on ClinicalTrials.gov

A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

607

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 2003

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Infliximab

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY

NCT00236028 - A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter